These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3482287)

  • 21. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
    Schulte C; Meurer M; Fröschl M
    Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
    Lusso P; Markham PD; Ranki A; Earl P; Moss B; Dorner F; Gallo RC; Krohn KJ
    J Immunol; 1988 Oct; 141(7):2467-73. PubMed ID: 3262661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum expression of human immunodeficiency virus antigen(s) in persons at risk. Evidence of disappearance of HIV-Ag during the developmental course of patients with acquired immunodeficiency syndrome].
    Leal M; Rey C; Pineda JA; García de Pesquera F; Navarro MD; Soto B; Sánchez-Quijano A; Lissen E
    Med Clin (Barc); 1987 Nov; 89(15):634-7. PubMed ID: 3481007
    [No Abstract]   [Full Text] [Related]  

  • 24. HIV-2, the West African AIDS virus.
    Clavel F
    AIDS; 1987 Sep; 1(3):135-40. PubMed ID: 3126752
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospects for a human immunodeficiency virus/AIDS vaccine.
    Murphy FA; Folks TM; Lairmore MD
    Dev Biol Stand; 1990; 72():3-15. PubMed ID: 1704324
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV mutation rate.
    Nowak M
    Nature; 1990 Oct; 347(6293):522. PubMed ID: 2215679
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in targeted therapy against human immunodeficiency virus [corrected].
    Broder S
    Crit Care Med; 1990 Feb; 18(2 Suppl):S118-25. PubMed ID: 2298027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
    Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
    Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A simple method for detecting HIV antibodies hidden in circulating immune complexes.
    Ujhelyi E; Büki B; Salavecz V; Banhegyi D; Horvàth A; Füst G; Hollàn SR
    AIDS; 1987 Sep; 1(3):161-5. PubMed ID: 3126757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunobiological aspects of AIDS].
    Khaitov RM; Liozner AL
    Mol Gen Mikrobiol Virusol; 1988 Sep; (9):3-8. PubMed ID: 3062391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AIDS virus can take on many guises.
    Marx JL
    Science; 1988 Aug; 241(4869):1039-40. PubMed ID: 2457946
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of the development of an AIDS vaccine.
    Lasky LA
    Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The AIDS virus.
    Gallo RC
    Sci Am; 1987 Jan; 256(1):46-56. PubMed ID: 3541200
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
    Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Possible use of anti-envelope immunotoxins against HIV-infection].
    Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
    Nihon Rinsho; 1989 Jan; 47(1):220-6. PubMed ID: 2786096
    [No Abstract]   [Full Text] [Related]  

  • 37. Pseudotype viruses bearing envelope antigens of Japanese isolates of human T-cell leukemia viruses type I.
    Hoshino H; Weiss RA; Clapham P; Miwa M; Miyoshi I; Yoshida M; Sugimura T
    Princess Takamatsu Symp; 1984; 15():159-64. PubMed ID: 6152758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of antibodies to the surface (anti-p-41) and nuclear protein (anti-p-24) of the human immunologic deficiency virus (HIV)].
    Hess G; Kroegel C; Ramadori G; Rieder H; Meyer zum Büschenfelde KH
    Med Klin (Munich); 1987 Oct; 82(21):723-5, 761. PubMed ID: 3500393
    [No Abstract]   [Full Text] [Related]  

  • 39. Part of AIDS virus is patented.
    Sun M
    Science; 1988 Feb; 239(4843):970. PubMed ID: 2830668
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B and AIDS and the promise for their control by vaccines.
    Hilleman MR
    Vaccine; 1988 Apr; 6(2):175-9. PubMed ID: 3291455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.